High-dose methotrexate-citrovorum factor rescue in the management of brain tumors
- PMID: 301782
Item in Clipboard
High-dose methotrexate-citrovorum factor rescue in the management of brain tumors
Cancer Treat Rep.
1977 Jul.
No abstract available
Similar articles
-
Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue.Cancer Treat Rep. 1978 Sep;62(9):1295-304. Cancer Treat Rep. 1978. PMID: 356984 Clinical Trial.
-
High-dose methotrexate with citrovorum factor rescue for the treatment of central nervous system tumors in children.Cancer Treat Rep. 1977 Jul;61(4):681-90. Cancer Treat Rep. 1977. PMID: 301781
-
High-dose methotrexate in malignant gliomas.Cancer Treat Rep. 1977 Jul;61(4):753-6. Cancer Treat Rep. 1977. PMID: 301785 No abstract available.
-
Methotrexate. II. Use in pediatric chemotherapy.Am J Pediatr Hematol Oncol. 1984 Winter;6(4):397-413. Am J Pediatr Hematol Oncol. 1984. PMID: 6398630 Review.
-
High-dose methotrexate with folinic acid rescue.Am J Hosp Pharm. 1977 Sep;34(9):961-5. Am J Hosp Pharm. 1977. PMID: 333910 Review.
Cited by
-
Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis.Clin Pharmacokinet. 2005;44(1):1-31. doi: 10.2165/00003088-200544010-00001. Clin Pharmacokinet. 2005. PMID: 15634030 Review.
-
Neoadjuvant chemotherapy in the treatment of recurrent glioblastomas (GBM).Ital J Neurol Sci. 1992 Oct;13(7):583-8. doi: 10.1007/BF02233401. Ital J Neurol Sci. 1992. PMID: 1428792
-
Carboxypeptidase displaying differential velocity in hydrolysis of methotrexate, 5-methyltetrahydrofolic acid, and leucovorin.J Bacteriol. 1978 May;134(2):506-13. doi: 10.1128/jb.134.2.506-513.1978. J Bacteriol. 1978. PMID: 26657 Free PMC article.
-
Prospective randomized cooperative medulloblastoma trial (MED 84) of the International Society of Paediatric Oncology (SIOP) and of the (German) Society of Paediatric Oncology (GPO).Childs Nerv Syst. 1987;3(2):70-3. doi: 10.1007/BF00271125. Childs Nerv Syst. 1987. PMID: 3304625 Clinical Trial.
-
Recurrent medulloblastoma. Lack of response to high-dose methotrexate.Cancer Chemother Pharmacol. 1983;10(2):135-6. doi: 10.1007/BF00446227. Cancer Chemother Pharmacol. 1983. PMID: 6831627 No abstract available.